Bal Pharma has submitted intimation regarding disbursement of final dividend for the FY 2025-26 and withholding of dividend in respect of shareholders with incomplete KYC/bank details or invalid, blocked or closed bank accounts.
The above information is a part of company’s filings submitted to BSE.